Bayer Proposes $7.25 Billion Roundup Settlement Amid Looming Supreme Court Case

Bayer’s Monsanto unit has proposed a $7.25 billion nationwide class settlement to resolve ongoing and future cancer lawsuits linked to its Roundup weedkiller. This strategic proposal comes as a critical Supreme Court case looms, adding significant pressure on the company to secure definitive legal certainty. The underlying lawsuits are based on allegations that the company failed to warn consumers about potential cancer risks associated with the product. By reaching this agreement, Bayer aims to end years of litigation that have heavily weighed on its market valuation and corporate outlook. While the payout is substantial, analysts suggest that achieving closure will allow the company to focus on debt reduction and its core business operations. The deal still requires court approval to become effective and legally binding for all claimants involved.